Wilson Sonsini Goodrich & Rosati advised ONI on the deal.ONI, a biotechnology company democratizing the ability to observe single molecules in living cells with its desktop…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
